These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17895169)

  • 61. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset.
    Furlan AJ; Eyding D; Albers GW; Al-Rawi Y; Lees KR; Rowley HA; Sachara C; Soehngen M; Warach S; Hacke W;
    Stroke; 2006 May; 37(5):1227-31. PubMed ID: 16574922
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial.
    Aqua K; Gimbel JS; Singla N; Ma T; Ahdieh H; Kerwin R
    Clin Ther; 2007 Jun; 29(6):1000-12. PubMed ID: 17692717
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Randomized trial of Cervene, a kappa receptor-selective opioid antagonist, in acute ischemic stroke.
    Lyden P
    J Stroke Cerebrovasc Dis; 1996; 6(1):3-4. PubMed ID: 17894957
    [No Abstract]   [Full Text] [Related]  

  • 64. Intra-arterial bone marrow mononuclear cells (BM-MNCs) transplantation in acute ischemic stroke (IBIS trial): protocol of a phase II, randomized, dose-finding, controlled multicenter trial.
    Moniche F; Escudero I; Zapata-Arriaza E; Usero-Ruiz M; Prieto-León M; de la Torre J; Gamero MA; Tamayo JA; Ochoa-Sepúlveda JJ; Maestre J; Carmona M; Piñero P; Calderón-Cabrera C; Jimenez MD; Gonzalez A; Montaner J
    Int J Stroke; 2015 Oct; 10(7):1149-52. PubMed ID: 26044701
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Neuroprotective effect of dapsone in patients with acute ischemic stroke: a pilot study.
    Nader-Kawachi J; Góngora-Rivera F; Santos-Zambrano J; Calzada P; Ríos C
    Neurol Res; 2007 Apr; 29(3):331-4. PubMed ID: 17509235
    [TBL] [Abstract][Full Text] [Related]  

  • 66. CHIMES-I: sub-group analyzes of the effects of NeuroAiD according to baseline brain imaging characteristics among patients randomized in the CHIMES study.
    Navarro JC; Chen CL; Lagamayo PD; Geslani MB; Eow GB; Poungvarin N; de Silva A; Wong LK; Venketasubramanian N;
    Int J Stroke; 2013 Aug; 8(6):491-4. PubMed ID: 23506216
    [TBL] [Abstract][Full Text] [Related]  

  • 67. AMPA antagonist ZK200775 in patients with acute ischemic stroke: possible glial cell toxicity detected by monitoring of S-100B serum levels.
    Elting JW; Sulter GA; Kaste M; Lees KR; Diener HC; Hommel M; Versavel M; Teelken AW; De Keyser J
    Stroke; 2002 Dec; 33(12):2813-8. PubMed ID: 12468775
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of a randomized phase 2 trial.
    Abciximab Emergent Stroke Treatment Trial (AbESTT) Investigators
    Stroke; 2005 Apr; 36(4):880-90. PubMed ID: 15731473
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial.
    Shyu WC; Lin SZ; Lee CC; Liu DD; Li H
    CMAJ; 2006 Mar; 174(7):927-33. PubMed ID: 16517764
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Safety and tolerability study of aptiganel hydrochloride in patients with an acute ischemic stroke.
    Dyker AG; Edwards KR; Fayad PB; Hormes JT; Lees KR
    Stroke; 1999 Oct; 30(10):2038-42. PubMed ID: 10512904
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Safety, tolerability and pharmacokinetics of MCI-186 in patients with acute ischemic stroke: new formulation and dosing regimen.
    Kaste M; Murayama S; Ford GA; Dippel DW; Walters MR; Tatlisumak T;
    Cerebrovasc Dis; 2013; 36(3):196-204. PubMed ID: 24135530
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators.
    Warach S; Pettigrew LC; Dashe JF; Pullicino P; Lefkowitz DM; Sabounjian L; Harnett K; Schwiderski U; Gammans R
    Ann Neurol; 2000 Nov; 48(5):713-22. PubMed ID: 11079534
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ninety-day administration of dl-3-n-butylphthalide for acute ischemic stroke: a randomized, double-blind trial.
    Cui LY; Zhu YC; Gao S; Wang JM; Peng B; Ni J; Zhou LX; He J; Ma XQ
    Chin Med J (Engl); 2013; 126(18):3405-10. PubMed ID: 24034079
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--II: neurologic outcome and efficacy analysis.
    Palesch YY; Hill MD; Ryckborst KJ; Tamariz D; Ginsberg MD
    Stroke; 2006 Aug; 37(8):2107-14. PubMed ID: 16809570
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Desmoteplase in Acute Ischemic Stroke (DIAS) clinical trial program.
    von Kummer R; Albers GW; Mori E;
    Int J Stroke; 2012 Oct; 7(7):589-96. PubMed ID: 22989394
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Controlling hypertension and hypotension immediately post stroke (CHHIPS)--a randomised controlled trial.
    Potter J; Mistri A; Brodie F; Chernova J; Wilson E; Jagger C; James M; Ford G; Robinson T
    Health Technol Assess; 2009 Jan; 13(9):iii, ix-xi, 1-73. PubMed ID: 19208305
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--I: Physiological responses and safety results.
    Ginsberg MD; Hill MD; Palesch YY; Ryckborst KJ; Tamariz D
    Stroke; 2006 Aug; 37(8):2100-6. PubMed ID: 16809571
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Safety and tolerability of GV150526 (a glycine site antagonist at the N-methyl-D-aspartate receptor) in patients with acute stroke.
    Dyker AG; Lees KR
    Stroke; 1999 May; 30(5):986-92. PubMed ID: 10229732
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients.
    Clark WM; Wechsler LR; Sabounjian LA; Schwiderski UE;
    Neurology; 2001 Nov; 57(9):1595-602. PubMed ID: 11706098
    [TBL] [Abstract][Full Text] [Related]  

  • 80. BNG-1 in the Recovery of Acute Ischemic Stroke: A phase 2, Double-blind, Placebo-controlled Randomized Trial.
    Chang YJ; Lee TH; Chang KC; Liou CW; Ryu SJ
    Acta Neurol Taiwan; 2015 Sep; 24(3)():73-81. PubMed ID: 27333830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.